HK1089691A1 - Enhancement of activity and/or duration of action of selected anti-inflammatory steroids - Google Patents

Enhancement of activity and/or duration of action of selected anti-inflammatory steroids

Info

Publication number
HK1089691A1
HK1089691A1 HK06111152A HK06111152A HK1089691A1 HK 1089691 A1 HK1089691 A1 HK 1089691A1 HK 06111152 A HK06111152 A HK 06111152A HK 06111152 A HK06111152 A HK 06111152A HK 1089691 A1 HK1089691 A1 HK 1089691A1
Authority
HK
Hong Kong
Prior art keywords
alkyl
duration
activity
inflammatory steroids
action
Prior art date
Application number
HK06111152A
Other languages
English (en)
Inventor
Nicholas S Bodor
Original Assignee
Nicholas S Bodor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas S Bodor filed Critical Nicholas S Bodor
Publication of HK1089691A1 publication Critical patent/HK1089691A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK06111152A 2003-06-19 2006-10-11 Enhancement of activity and/or duration of action of selected anti-inflammatory steroids HK1089691A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47949703P 2003-06-19 2003-06-19
PCT/US2004/019368 WO2004112800A1 (en) 2003-06-19 2004-06-17 Enhancement of activity and/or duration of action of selected anti-inflammatory steroids

Publications (1)

Publication Number Publication Date
HK1089691A1 true HK1089691A1 (en) 2006-12-08

Family

ID=33539182

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06111152A HK1089691A1 (en) 2003-06-19 2006-10-11 Enhancement of activity and/or duration of action of selected anti-inflammatory steroids

Country Status (7)

Country Link
US (2) US7419971B2 (xx)
EP (1) EP1658083B1 (xx)
AT (1) ATE369138T1 (xx)
CA (1) CA2558941C (xx)
DE (1) DE602004008083T2 (xx)
HK (1) HK1089691A1 (xx)
WO (1) WO2004112800A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799331B2 (en) * 2005-08-04 2010-09-21 Taro Pharmaceutical North America, Inc. Oral suspension of prednisolone acetate
US7687484B2 (en) 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
US7691811B2 (en) 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
US20080242646A1 (en) * 2007-03-26 2008-10-02 Lessem Jan N Split dose corticosteroid therapy
KR20200130287A (ko) 2018-02-08 2020-11-18 이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. 헤테로아릴 화합물, 이의 약학 조성물 및 이의 치료적 용도
EP3976600A1 (en) 2019-06-03 2022-04-06 Biotheryx, Inc. Non-hygroscopic crystalline salts of a pyrazole compound, and pharmaceutical compositions and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1384372A (en) 1971-01-20 1975-02-19 Glaxo Lab Ltd Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids
US3828080A (en) * 1972-01-20 1974-08-06 Glaxo Lab Ltd Androstane-17beta-carboxylic acids and processes for the preparation thereof
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
CH628355A5 (de) 1976-02-24 1982-02-26 Ciba Geigy Ag Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.
US4710495A (en) 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity
US4996335A (en) 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
WO1991007186A1 (en) * 1989-11-21 1991-05-30 The University Of Melbourne Anti-inflammatory compositions and methods
US5981517A (en) * 1996-05-09 1999-11-09 Soft Drugs, Inc. Androstene derivatives
TW503113B (en) 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액

Also Published As

Publication number Publication date
CA2558941C (en) 2012-05-15
DE602004008083D1 (de) 2007-09-20
WO2004112800A1 (en) 2004-12-29
US7419971B2 (en) 2008-09-02
EP1658083B1 (en) 2007-08-08
CA2558941A1 (en) 2004-12-29
DE602004008083T2 (de) 2008-04-24
US20050020551A1 (en) 2005-01-27
US20080261930A1 (en) 2008-10-23
US7776846B2 (en) 2010-08-17
ATE369138T1 (de) 2007-08-15
EP1658083A1 (en) 2006-05-24

Similar Documents

Publication Publication Date Title
HK1089690A1 (en) Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application
HK1089691A1 (en) Enhancement of activity and/or duration of action of selected anti-inflammatory steroids
MX2009004616A (es) Metodos de tratamiento hormonal que utilizan regimenes de ciclo extendido de dosis ascendente.
TW200603813A (en) Cyclic progestin regimens and kits
TW200626161A (en) Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
EP1694700A4 (en) NEUTRALIZED HGF EPITOPE AND NEUTRALIZING ANTIBODY RELATED THERETO
GEP20094780B (en) Prostaglandin nitrooxyderivatives
DE60216630D1 (de) Verwendung von öestrogen in kombination mit progestogen für die hormonsubstitutions-therapie
TW200617022A (en) Anti-glypican 3 antibody
CO5700776A2 (es) Compuestos utiles para el tratamiento de enfermedades
ATE411353T1 (de) Silikonzusammensetzung, die durch hydrosilylierung in gegenwart eines carben-metall-katalysators vernetzt werden kann und katalysator
JO2672B1 (en) Progesterone receptor antagonists
NZ524104A (en) Exemestane as chemopreventing agent
DE60313164D1 (de) Allylsilan enthaltende Zusammensetzung
EP1558766A4 (en) USE OF A33 ANTIGENES AND JAM IT
BRPI0603783A (pt) composições e métodos para redução do ph vaginal
TW200720842A (en) A squarilium compound and the short-wave length source photo polymerization composition using thereof
ATE492282T1 (de) Zusammensetzung aus steroiden mit transporterweiterter corticosteroid-aktivität
HK1088028A1 (en) Use of metal alkanedithiols as crosslkinking agents for unsaturated rubbers
TW200714602A (en) 5,6-dialkyl-7-aminoazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds
JPS53130509A (en) Totally-enclosed motor compressor
ATE419855T1 (de) Therapie für hormonersatz und depression enthaltend dienogest
MXPA05008347A (es) Composicion que comprende una combinacion de un inhibidor de aromatasa, una progestina y un estrogeno y su uso para el tratamiento de endometriosis.
RS101004A (xx) Upotreba novih estara etonogestrela
PL1709057T3 (pl) Synteza spongozyny

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180617